sertraline has been researched along with 2019 Novel Coronavirus Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghaeepour, N; Maric, I; Oskotsky, B; Oskotsky, T; Sirota, M; Stevenson, DK; Tang, A; Wong, RJ | 1 |
| Amici, E; De Filippis, S; Di Giovanni, A; Giovanetti, V; Kotzalidis, GD; Lombardozzi, G; Matrone, M; Perrini, F; Trovini, G | 1 |
| Chen, S; Chen, Y; Guo, J; Guo, Y; He, X; Jiang, S; Li, L; Li, X; Li, Z; Liu, S; Lu, L; Ma, C; Pan, X; Qiu, M; Tan, S; Wen, M; Wu, D; Wu, Y; Xu, W; Yang, C; Zhan, Q; Zhang, N | 1 |
| Dela Cruz, CS; Dong, X; Jiao, T; Lei, X; Ren, L; Sharma, L; Wang, C; Wang, J; Wang, Y; Xiao, X; Zhao, Z | 1 |
| Frankle, WG; Lequesne, E; Rohs, A; Zhang, E | 1 |
5 other study(ies) available for sertraline and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; COVID-19; Cytokines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Prescription Drugs; Retrospective Studies; Risk; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; United States | 2021 |
Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma.
Topics: Adult; Antidepressive Agents; COVID-19; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Sertraline; Trazodone; Treatment Outcome; Vortioxetine | 2022 |
Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
Topics: Animals; Antiviral Agents; COVID-19; Humans; Mice; SARS-CoV-2; Sertraline; Spike Glycoprotein, Coronavirus; Virus Internalization | 2022 |
Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2.
Topics: Animals; Antiviral Agents; Cell Line; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Fendiline; HEK293 Cells; High-Throughput Screening Assays; Humans; Monensin; Pandemics; Salicylanilides; SARS-CoV-2; Sertraline; Vortioxetine | 2020 |
Suspected Recurrence of Symptomatic COVID-19: Management During Inpatient Psychiatric Treatment.
Topics: Adult; Alcoholism; Antidepressive Agents; Antipsychotic Agents; Clozapine; COVID-19; COVID-19 Nucleic Acid Testing; Depressive Disorder, Major; Hospitals, Psychiatric; Humans; Inpatients; Male; Mirtazapine; Psychotic Disorders; Recurrence; SARS-CoV-2; Sertraline; Suicide, Attempted | 2021 |